Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (1149)	5/31/2000 3:21:00 AM
From: Torben Noerup Nielsen	Read Replies (1) \| Respond to of 52153

Miljenko, Unless Mitch Sayare is lying through his teeth, their current combination is not toxic on a systemic basis. That's what interests me the most. According to the statements of Immunogen to date, there has been no toxicity. And one can infer from their web site that the patients dosed have shown no cancer progression. Halting the progression of the cancer without systemic toxicity would be a nice result. Thanks, Torben